Madrigal Pharmaceuticals (NASDAQ:MDGL) Upgraded at StockNews.com
StockNews.com upgraded shares of Madrigal Pharmaceuticals (NASDAQ:MDGL – Free Report) to a sell rating in a research note issued to investors on Wednesday morning. Several other equities research analysts have also weighed in on MDGL. Cantor Fitzgerald restated a neutral rating on shares of Madrigal Pharmaceuticals in a report on Tuesday, July 23rd. JMP Securities […]
5 Oct 19:26 · The Cerbat Gem